Leaders in Learning: Publications of Faculty & Staff


Department of Medicine: 2000-2001



ADAMS, P.C.

Adams, P.C. 2000. Inherited liver disease. First Principles of Gastroenterology: The Basis of Disease and an Approach to Management. 4th ed. A.B.R. Thomson, and E.A. Shaffer. Mississauga: Astra Pharmaceuticals Canada, Limited/Astra Pharmaceutiques Canada Itee. 554-559.

Adams, P.C. 2001. Iron overload in Montpellier. Gut 48 (6): 753-756.

Adams, P.C. 2001. Is there a threshold of hepatic iron concentration for the development of cirrhosis in C282Y hemochromatosis? American Journal of Gastroenterology 96 (2): 567-569.

Adams, P.C. 2000. Non-expressing C282Y homozygotes for hemochromatosis: minority or majority of cases? Molecular Genetics and Metabolism 71 (1-2): 81-86.

Adams, P.C. 2000. Unsaturated iron binding capacity: a screening test for hemochromatosis? Clinical Chemistry 46: 1870.

Adams, P.C. 2000. Update on hemochromatosis. Evidence-Based Gastroenterology. J.W.D. McDonald, A. Burroughs, and B. Feagan. London: BMJ Books.

Adams, P.C., P. Brissot, A. Pietrangelo, and Powell L.W. 2000. EASL international consensus conference on heamochromatosis. Journal of Hepatology 33: 485-505.

Collier, J., P.C. Adams, V. Feinman, C. Ghent, H. Witt-Sullivan, G. Minuk, M. Krajden, and J. Heathcote. 2000. Long term follow up of patients with chronic hepatitis C treated with alpha interferon. Canadian Journal of Gastroenterology 14: 77B-80B.

McLaughlin, K., S. Wajstaub, P.J. Marotta, P.C. Adams, D.R. Grant, W.J. Wall, A.M. Jevnikar, and K.S. Rizkalla. 2000. Increased risk for post-transplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transplantation 6 (5): 570-574.
 
 

ARNOLD, J.M.O.

Aikawa, Y., L. Rohde, J. Plehn, S.C. Greaves, F. Menapace, J.M.O. Arnold, J.L. Rouleau, M.A. Pfeffer, R.T. Lee, and S.D. Solomon. 2001. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial in the Healing and. American Heart Journal (141)

Arnold, J.M.O. 2000. Heart and blood vessel disorders: The Merck Manual of Medical Infromation - Home Edtion. Edition 2 ed. West Point, PA: The Merck Manuals, Merck & Co., Inc.

Arnold, J.M.O. 2000. The treatment of heart failure (Chapter 4). Melmon and Morrelli's Clinical Pharmacology: Basic Principles in Therapeutics. 4th ed. S.G. Carruthers, B.B. Hoffman, K.L. Melmon, and D.W. Nierenberg. New York: McGraw-Hill. 157-182.

Arnold, J.M.O., W. Czarnecki, J.D. Parker, J. Howlett, A. Ignaszewski, S. Smith, and A.R.J. ARajakumar. 2001. Community versus congestive heart failure (CHF) clinic drug utilization: The Canadian CHF clinics network 1999-2000. Journal of Molecular and Cellular Cardiology 33 (6): A25.

Arnold, J.M.O., J.D. Parker, J.G. Howlett, A.P. Ignaszewski, S.J. Smith, W. Czarnecki, M.-H. LeBlanc, P. Liu, A.R.J. Rajakumar, I. Belenkie, and D. Manyari. 2000. Changes in drug utilization in specialised Heart Failure Clinics during 1999: the Canadian CHF Clinics Networks Experience. Canadian Journal of Cardiology 16 (Suppl F): 119F.

Arnold, J.M.O., J.D. Parker, J.G. Howlett, A.P. Ignaszewski, S.J. Smith, W. Czarnecki, M.-H. LeBlanc, P. Liu, A.R.J. Rajakumar, I. Belenkie, and D. Manyari. 2000. Changes in heart failure drug utilization during 1999:the Canadian CHF Clinics Network experience. Journal of Cardiac Failure 6 (3, Suppl 2): 78.

Arnold, J.M.O., J.D. Parker, J.G. Howlett, A.P. Ignaszewski, S.J. Smith, W. Czarnecki, M.-H. LeBlanc, P. Liu, A.R.J. Rajakumar, I. Belenkie, and D. Manyari. 2001. Changes in heart failure drug utilization during 1999:the Canadian CHF Clinics Network experience. Journal of the American College of Cardiology 37 (2, SupplA): 197A.

Arnold, J.M.O., J.D. Parker, J.G. Howlett, A.P. Ignaszewski, S.J. Smith, W. Czarnecki, M.-H. LeBlanc, P. Liu, and A.R.J. Rajakumar. 2000. Current treatment in hospital based outpatient heart failure clinics: the Canadian CHF Clinics Network. European Journal of Heart Failure 2 (Suppl 2): 23.

Arnold, J.M.O., J.D. Parker, J.G. Howlett, A.P. Ignaszewski, S.J. Smith, W. Czarnecki, M.-H. LeBlanc, P. Liu, A.R.J. Rajakumar, and I. Belenkie. 2001. Drug utilization trends in patients seen in the Canadian CHF clinic network Jan 1999-June 2000. European Journal of Heart Failure 3 (Suppl): 5109-5110.

Dzeka, T.N., B. Derylo, and J.M.O. Arnold. 2000. Endothelial function and prostaglandins in human veins. Canadian Journal of Cardiology 16 (Suppl F): 193F.

Dzeka, T.N., P. Kuzminski, and J.M.O. Arnold. 2000. Venous responsivenous to norepinephrine in healthy subjects: Effects of single doses of 325 mg aspirin. Clinical Pharmacology & Therapeutics (2000)

Feng, Q.P., M.L. Lambert, I.D. Callow, and J.M.O. Arnold. 2000. Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure. Clinical Pharmacology & Therapeutics 67: 292-298.

Feng, Q.P., X. Lu, D.L. Jones, J. Shen, and J.M.O. Arnold. 2001. Increased inducible nitric oxide synthase expression contributes to myocardiol dysfunction and. Circulation 104: 700-704.

Feng, Q.P., X.R. Lu, J. Shen, and J.M.O. Arnold. 2000. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and. Nitric Oxide 4: 318-319.

Feng, Q.P., X.R. Lu, J. Shen, and J.M.O. Arnold. 2000. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality post myocardial infarction in mice. Canadian Journal of Cardiology 16 (Suppl F): 181F.

Gupta, A., and J.M.O. Arnold. 2000. Can I be sure my patient has Congestive Heart Failure? Perspectives In Cardiology 16 (2): 26-38.

The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (J.M.O. Arnold, Member). 2000. Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high risk patients. New England Journal of Medicine 342 (3): 145-153.

The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (J.M.O. Arnold, Member). 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. New England Journal of Medicine 342 (3): 154-160.

The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (J.M.O. Arnold, Member of International Steering Committee, Member of Events Adjudication Committee, Regional Coordinator for SW Ontario, PI in Victoria Hospital, London). 2000. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. The Lancet 355 (9200): 253-259.

IMPRESS investigators (J.M.O. Arnold member of the IMPRESS study group). 2000. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity. The Lancet 356 (9230): 615-620.

LeBlanc, M.H., J.M.O. Arnold, S. Belenkie, C. Czarnecki, J. Howlett, A. Ignaszewski, P. Liu, D. Manyari, A. Parker, R. Rajakumar, S. Smith, and K. Teo. 2000. Women and heart failure: First year data from the Canadian Clinics Network. Canadian Journal of Cardiology 16 (Suppl F): 217F.

Manes, C., J.D. Rutherford, S. Greaves, J.-L. Rouleau, J.M.O. Arnold, F. Menapace, M.A. Pfeffer, and S.D. Solomon. 2000. Value of ST segment elevation in predicting recovery of Left Ventricular Function after Q-wave anterior myocardial infarction - The Healing and Early Afterload Reducing Therapy (HEART) trial. Circulation 102 (18): II-685.

Moe, G.W., J.L. Rouleau, L. Charbonneau, G. Proulx, J.M. Arnold, C. Hall, J. de Champlain, A. Barr, P. Sirois, and M. Packer. 2000. Neurohormonal activation in severe heart failure. Relations to patient mortality and the effect of treatment with flosequinan. American Heart Journal 139 (4): 587-595.

Solomon, S.D., R. Glynn, S. Greaves, U. Ajani, J.-L. Rouleau, F. Menapace, J.M.O. Arnold, R.T. Lee, C. Hennekens, and M.A. Pfeffer. 2001. Regional wall stress predicts remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (H.E.A.R.T.): an echocardiography-based structural analysis. American Heart Journal 141 (2): 234-242.

Solomon, S.D., R.J. Glynn, S. Greaves, U. Ajani, J.L. Rouleau, F. Menapace, J.M. Arnold, C. Hennekens, and M.A. Pfeffer. 2001. Recovery of ventricular function following myocardial infarction in the reperfusion era: The HEART study. Annals of Internal Medicine 134 (6): 451-458.

Solomon, S.D., M.G. St. John Sutton, J.L. Rouleau, T. Plappert, H. Skali, L.A. Moye, J.M.O. Arnold, B.A. Sussex, and M.A. Pfeffer. 2000. Left Ventricular Remodeling Does Explain the Increased Incidence Congestive Heart Failure in Diabetics. The Save Experience. Circulation 102 (18): II-28.

Strathopulos, P.B., X. Lu, J.A. Scott, J. Hammond, D.G. McCormack, J.M.O. Arnold, and Q.P. Feng. 2001. Increased L-arginine uptake and inducible nitric oxide activity in the aorta of heart failure rats: Role of L-arginine transport in nitric oxide production. American Journal of Physiology 280 (2): H859-H867.

Teasell, R.W., J.M.O. Arnold, A. Krassioukov, and G.A. Delaney. 2000. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Archives of Physical Medicine and Rehabilitation 81: 506-516.

Udelson, J.E., G. Antonopoulos, G. Proulx, B.A. Sussex, J.M.O. Arnold, S. Kouz, S.S. Mehta, and M.A. Konstam. 2000. Comparison of long-term dual vasopeptidase inhibition with Omapatrilat to ACE Inhibition with Lisinopril. Journal of Cardiac Failure 6 (3, Suppl 2): 45.

Udelson, J.E., G. Antonopoulos, G. Proulx, B.A. Sussex, J.M.O. Arnold, S. Kouz, S.S. Mehta, and M.A. Konstam. 2000. Comparison of long-term dual vasopeptidase inhibition with Omapatrilat to ACE Inhibition with Lisinopril. Circulation 102 (18): II-536.
 
 

BLAKE, P.G.

Blake, P.G. 2000. Comparative survival in hemodialysis and peritoneal dialysis. Nefrologia 20 (Suppl 3): 12-15.

Blake, P.G. 2000. Comparison between DOQI and Canadian Guidelines on peritoneal dialysis. Peritoneal Dialysis International 20 (5): 487-492.

Blake, P.G. 2000. Creatinine is the best molecule to target adequacy of peritoneal dialysis. Peritoneal Dialysis International 20 (suppl 2): S65-S69.

Blake, P.G. 2000. Trends in patient and technique survival in peritoneal dialysis and strategies: How are we doing and how can we do better? Advances in Renal Replacement Therapy 7 (4): 324-337.

Blake, P.G., A. Breborowicz, D.S. Nad, P. Joffe, S.M. Korbet, and B.A. Waradyfor the International Society of Peritoneal Dialysis (ISPD) Standards and Education Committee. 2000. ISPD Guidelines/Recommendations: Recommended Peritoneal Dialysis Curriculum for Nephrology Trainees. Peritoneal Dialysis International 20 (5): 497-502.

Blake, P.G., S.M. Korbet, R. Blake, J.M. Bargman, J.M. Burkhart, B.G. Delano, M.K. Dasgupta, A. Fine, F. Finkelstein, F.X. McCusker, S.D. McMurray, P.M. Szabetakis, S.W. Zimmerman, and P. Heidenheim. 2000. A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients. American Journal of Kidney Diseases 35: 506-514.

Blake, P.G., W. Van Biesen, N. Lameire, and R. Maiorca. 2000. Outcomes and intermodality transfers in patients on renal replacement therapy (RRT) in Canada. Complications of Dialysis - Recognitition and Management. N. Lameire, and S. Mehta. New York: Marcel Dekker. 791-810.

Garg, A.X., P.G. Blake, W.F. Clark, C.M. Clase, R.B. Hanes, and L.M. Moist. 2001. The association between renal insufficiency and malnutrition in community-dwelling older adults. Journal of the American Society of Nephrology 12: A1053.

Garg, A.X., P.G. Blake, W.F. Clark, C.M. Clase, R.B. Haynes, and L.M. Moist. 2001. Association between renal insufficiency and malnutrition in older adults: results from the NHANES III. Kidney International 60 (5): 1867-1874.

Mjais, S., K. Nolph, R. Gokal, P. Blake, J. Burkart, G. Coles, Y. Kawaguchi, H. Kawanishi, S. Korbet, R. Krediet, B. Lindholm, D. Oreopoulos, B. Rippe, and R. Selgas. 2000. Evaluation and management of ultrafiltartion problems in peritoneal dialysis. Peritoneal Dialysis International 20 (4): 5-21.

Perez, R.A., P.G. Blake, S. McMurray, L. Mupas, and D. Oreopoulos. 2000. What is the optimal frequency of cycling in automated peritoneal dialysis (APD)? Peritoneal Dialysis International 20 (5): 548-556.

Perez, R.A., P.G. Blake, E. Spanner, M. Patel, S. McMurray, P. Heidenheim, and R.M. Lindsay. 2000. High creatinine excretion ratio predicts a good outcome in peritoneal dialysis patients. American Journal of Kidney Diseases 36 (2): 362-367.

Perez, R.A., E. Spanner, A.P. Heidenheim, and P.G. Blake. 2000. Prevalence and predictors of iron deficiency in a population with advanced chronic renal failure. Journal of the American Society of Nephrology 11: A0402.

Perez, R.A., E. Spanner, B.P. Heidenheim, and P.G. Blake. 2000. C-Reactive protein (CRP) levels and their predictors in an advanced chronic renal failure (CRF). Journal of the American Society of Nephrology 11: A0403.

Suri, R., A.P. Heidenheim, and P.G. Blake. 2000. Iron deficiency or anemia of chronic inflammation: Are we overtreating with Iron? Journal of the American Society of Nephrology 12: A2129.
 
 

BORRIE, M.J.

Borrie, M.J. 2000. Impact of Nurse/Physician Continence Clinic Intervention of Health Care Costs. Clinical and Investigative Medicine 23: 332.

Borrie, M.J. 2000. Prevalence of and factors associated with inappropriate prescribing in long term care facilities. Clinical and Investigative Medicine 23: 332.

Misiaszek, B.C., M.J. Borrie, R.E. Grymonpre, and C.D. Brymer. 2001. Canadian University Faculties of Pharmacy: Undergraduate Curriculum Survey of Geriatric Content. American Journal of Pharmaceutical Education 65: 1-10.
 
 

BOUGHNER, D.R.

Boughner, D.R. 2000. The pericardial bioprosthesis: altered tissue shear properties following glutaraldehyde fixation. The Journal of Heart Valve Disease 9 (6): 752-760.

Boughner, D.R. 2000. The radiographic quantitation of aortic valve calcification: implications for assessing bioprosthetic valve calcification in vitro. Physiol Measurements. 21: 409-416.

Chow, L.H., D.R. Boughner, J. Dunmore-Buyze, H. Finlay, and J.G. Pickering. 2001. Enhanced detection of cardiac muscle damage by polarized light microscopy: Use in a model of coxsackievirus B3-induced myocarditis. Journal of Cardiovascular Pathology 10: 83-86.

De Groot, C., M. Drangova, A. Fenster, S. Zhu, P.W. Pflugfelder, and D.R. Boughner. 2000. Evaluation of 3D colour Doppler ultrasound for the measurement of proximal iso-velocity surface area. Ultrasound in Med & Biol. 26 (6): 989-999.

Guo, Z. 2001. Quantitative assessment of in vitro jets based on three-dimensional color Doppler reconstruction. Ultrasound in Medicine & Biology 27 (2): 235-2343.

Nadkarni, S.K. 2001. In vitro simulation and quantifaction of temporal jitter artifacts in ECG-gated dynamic three-dimensional echocardiography. Ultrasound in Medicine & Biology 27 (2): 211-22.

Nadkarni, S.K., D.R. Boughner, M. Drangova, and A. Fenster. 2000. Three-dimensional echocardiography: assessment of inter-and intra-operator variability and accuracy in the measurement of left ventricular cavity volumes and myocardial masses. Phys Med Biol. 46: 1255-73.

Quinn, R.R. 2000. Intracoronary ultrasound imaging: methods and clinical applications. Canadian Journal of Cardiology 16: 911-17.

Weind, K.L., C.G. Ellis, and D.R. Boughner. 2001. The aortic valve blood supply. Journal of Heart Valve Disease 9: 1-8.
 
 

BROWN, J.E.

Burns, K.E., K.A. Ferguson, A. Spouge, and J.E. Brown. 2001. Massive congenital coronary arteriovenous malformation presenting with exertional dyspnea and desaturation in an adult: a case report and review of the literature. Canadian Journal of Cardiology 17 (1): 85-89.

Zalai, C.V., M.D. Kolodziejczyk, L. Pilrski, A. Christov, P.N. Nation, M. Lundstorm-Hobman, W. Tymchak, V. Dzavic, D. Humen, W. Kostuk, G. Jablonsky, P. Pflugfelder, and L.A. Brown. 2001. Increased circulating monocyte activation in patients with unstable coronary syndromes. Journal of the American College of Cardiology 38 (5): 1340-1347.
 
 

BRYMER, C.D.

Brymer, C., P. Cavanagh, E. Denomy, K. Wells, and C. Cook. 2001. The Effect of a Geriatric Education Program on Emergency Nurses. Journal of Emergency Nursing 27: 27-32.

Brymer, C., and I. Rusnell. 2000. Reducing substance dependence in elderly people: The Side Effects Program. Canadian Journal of Clinical Pharmacology 7: 161-166.

Gill, S.S., B.C. Misiaszek, and C. Brymer. 2001. Improving prescribing in the elderly: A study in the long term care setting. Canadian Journal of Clinical Pharmacology 8 (78-83)

Misiaszek, B.C., M.J. Borrie, R.E. Grymonpre, and C.D. Brymer. 2001. Canadian University Faculties of Pharmacy: Undergraduate Curriculum Survey of Geriatric Content. American Journal of Pharmaceutical Education 65: 1-10.
 
 

CHIN-YEE, I.H.

d'Almeida, M.S., M. Duggan, M. White, J. Jagger, C. Ellis, and I.H. Chin-Yee. 2000. A Comparison of biochemical and functional alterations of rat and human erythrocytes stored in. Transfusion Medicine 10 (4): 291-303.

Eichelbronner, O., A. Sielenkamper, G. Cepinskas, W.J. Sibbald, and I.H. Chin-Yee. 2000. Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow. Critical Care Medicine 28 (6): 1865-1870.

Hebert, P.C., I.H. Chin-Yee, and Blajchman. 2000. Should Old Red Cells Be Transfused in Critically Ill Patients. Yearbook of Critical Care and Emergency Medicine. J.L. Vincent. Heidelberg: Springer. 494-506.

Rock, G., I.H. Chin-Yee, G. Cantin, A. Giulivi, S. Gluck, A. Keating, M. Keeney, J. Klassen, R. Sutherland, and the Canadian Apheresis Group and Canadian Bone Marrow Transplant Group. 2000. Quality Assurance of Progenitor Cell Content of Apheresis Products: A Comparison of Clonogenic Assays and CD34+ Enumeration. Transfusion Medicine 10: 67-75.

Rosu-Myles, M., M. Khandaker, D.M. Wu, M. Keeney, S.R. Fowley, K. Howson-Jan, I.H. Chin-Yee, F. Fellows, D. Kelvin, and M. Bhatia. 2000. Characterization of chemokine receptors expressed in cells during human hematopoietic ontogeny. Stem Cells 18: 374-381.

Sielenkamper, A.W., O. Eichelbronner, C.M. Martin, S.W. Mador, I.H. Chin-Yee, and W.J. Sibbald. 2000. Diaspirin crosslinked hemoglobin improves mucosal perfusion in ileum of septic rats. Critical Care Medicine 28 (3): 782-787.

Sielenkamper, A.W., P. Yu, O. Eichelbronner, T. MacDonald, C.M. Martin, I.H. Chin-Yee, and W.J. Sibbald. 2000. Diaspirin cross-linked HB and norepinephrine prevent the sepsis-induced increase in critical O(2) delivery. American Journal of Physiology-Heart and Circulatory Physiology 279 (4): H1922-H1930.
 
 

CHOW, L.H.

Chow, L.H., D.R. Boughner, J. Dunmore-Buyze, H. Finlay, and J.G. Pickering. 2001. Enhanced detection of cardiac muscle damage by polarized light microscopy: Use in a model of coxsackievirus B3-induced myocarditis. Journal of Cardiovascular Pathology 10: 83-86.

Li, J., X. Han, J. Jiang, R. Zhong, G.M. Williams, J.G. Pickering, and L.H. Chow. 2001. Vascular smooth muscle cells of recipient origin mediate intimal expansion following aortic allotransplantation in mice. American Journal of Pathology 158: 1943-1947.

Li, S., L.H. Chow, and J.G. Pickering. 2000. Cell surface-bound collagenase-1 and focal substrate degradation stimulate the rear release of motile vascular smooth muscle cells. Journal of Biological Chemistry 275: 35384-35392.
 
 

CLARK, W.F.

Clark, W.F. 2001. Pulmonary hemorrhage with rapidly progressive kidney failure. Canadian Journal of Diagnosis 18: 111-120.

Clark, W.F. 2000. What's new in lupus nephritis? Canadian Journal of Continuing Medical Education 12: 195-203.

Clark, W.F., D.N. Churchill, L. Forwell, G. MacDonald, and S. Foster. 2000. To pay or not to pay? A decision and cost-utility analysis from the state perspective of ACE-inhibitor therapy for diabetic nephropathy. Canadian Medical Association Journal 162: 195-198.

Clark, W.F., C. Kortas, A.P. Heidenheim, J. Garland, E. Spanner, and A. Parbtani. 2001. Flaxseed in Lupus Nephritis: A two year nonplacebo-controlled Study. Journal of the American College of Nutrition 20: 143-148.

Clark, W.F., A.D. Muir, N.D. Westcott, and A. Parbtani. 2000. A novel treatment for lupus nephritis: lignan precursor derived from flax. Lupus 9: 429-436.

Cohen, B.A., and W.F. Clark. 2000. Pauci-immune renal vasculitis:Natural history, prognostic factors, and impact of therapy in 94 patients. American Journal of Kidney Diseases 36: 914-924.

Garg, A.X., P.G. Blake, W.F. Clark, C.M. Clase, R.B. Hanes, and L.M. Moist. 2001. The association between renal insufficiency and malnutrition in community-dwelling older adults. Journal of the American Society of Nephrology 12: A1053.

Garg, A.X., P.G. Blake, W.F. Clark, C.M. Clase, R.B. Haynes, and L.M. Moist. 2001. Association between renal insufficiency and malnutrition in older adults: results from the NHANES III. Kidney International 60 (5): 1867-1874.

Rehman, F., A.X. Garg, and W.F. Clark. 2001. Thrombotic thrombocytopenic purpura - Hemolytic uremic syndrome. Canadian Journal of Continuing Medical Education 13: 85-94.
 
 

CRILLY, R.G.

Crilly, R.G., R.J. Sebaldt, A.B. Hodsman, J.D. Adachi, J.P. Brown, C. Goldsmith, D.A. Hanley, and W. Olszynski. 2000. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial response in patients with osteoporosis. Osteoporosis International 11: 607-614.

McKercher, H.G. 2000. Osteoporosis Management in the Long Term Care Setting: A Survey of Ontario Physicians. Canadian Family Physician 46: 2228-2235.

McKercher, H.G., and R.G. Crilly. 2000. Continuing Education in Geriatrics: The Needs of Physicians in northeastern Ontario. Mature Medicine Canada 3 (2): 64-68, 72.

Misiaszek, B.C., M.J. Borrie, R.E. Grymonpre, and C.D. Brymer. 2001. Canadian University Faculties of Pharmacy: Undergraduate Curriculum Survey of Geriatric Content. American Journal of Pharmaceutical Education 65: 1-10.
 
 

DIAS, B.

Dias, B., H. El-Haji, R. Cusimano, J. Graba, A. Velups, and J. Butany. 2001. Coexisting Ventricular Septal Aneurysms: Congenital and Postmyocardial Infarction. Canadian Journal of Cardiology 17: 1193-1196.

Dias, B., J. Graba, S. Siu, J. Rouleau, T. Yau, and J. Butany. 2001. Papillary Muscle Rupture. Canadian Journal of Cardiology 17: 722-723.

Dias, B., T. Parker, A. Ralph-Edwards, J. Ross, A. Velups, and J. Butany. 2001. Surgical Mastectomy in Obstructive Hypertrophic Cardiomyopathy. Canadian Journal of Cardiology 17: 1087-1089.

Dias, B., H. Scully, R. Black, R.M. Iwanochko, J. Graba, and J. Butany. 2001. Acute Bacterial Endocarditis on Myxomatous Mitral Valve. Canadian Journal of Cardiology 17: 983-985.

Dias, B., T. Yau, Z. Sasson, R. Leask, J. Persaud, and J. Butany. 2001. Right Atrial Mass. Canadian Journal of Cardiology 17: 1299-1300.

Dias, B.F., Yum E.H., C.E. Sloggett, R.M. Iwanochko, H. Rakowski, and S.C. Siu. 2001. Contrast Enhanced Quantitation of Left Ventricular Ejection Fraction: What is the best method? Journal of the American Society of Echocardiography 14: 1183-1190.
 
 

FEAGAN, B.G.

Feagan, B.G. 2001. A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. Pharmacotherapy 21 (7 pt 2): 89S-94S.

Feagan, B.G. 2000. Infliximab in the treatment of Crohn's disease. Canadian Journal of Gastroenterology (Suppl C): 6C.

Feagan, B.G. 2001. Safety of biologics: current issues and future concerns. Acta Gastroenterology Belgium 64 (2): 210-214.

Feagan, B.G. 2001. Standard immunosuppression in IBD: current practice. Acta Gastroenterology Belgium 64 (2): 182-188.

Feagan, B.G., R. Enns, R.N. Fedorak, R. Panaccione, P. Pare, A.H. Steinhart, and G. Wild. 2001. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics. Canadian Journal of Clinical Pharmacology 8 (4): 188-198.

Feagan, B.G., T.J. Marrie, C.Y. Lau, S.L. Wheeler, C.J. Wong, and M.K. Vandervoort. 2000. A critical pathway for treatment of community-acquired pneumonia. JAMA 283 (20): 2654-2655.

Feagan, B.G., and J.W. McDonald. 2001. Mesalamine maintenance therapy for Crohn's disease. Gastroenterology 120 (2): 585-586.

Feagan, B.G., C.J. Wong, A. Kirkley, D.W. Johnston, F.C. Smith, P. Whitsitt, S.L. Wheeler, and C.Y. Lau. 2000. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Annals of Internal Medicine 133 (11): 845-854.

Feagan, B.G., C.J. Wong, C.Y. Lau, S.L. Wheeler, G. Sue-A-Quan, and A. Kirkley. 2001. Transfusion practice in elective orthopaedic surgery. Transfusion Medicine 11 (2): 87-95.

Fedorak, R.N., A. Gangl, C.O. Elson, P. Rutgeerts, S. Schreiber, G. Wild, S.B. Hanauer, A. Kilian, M. Cohard, A. LeBeaut, and B.G. Feagan. 2000. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 119 (6): 1473-1482.

Irvine E.J., G.R. Greenberg, B.G. Feagan, F. Martin, L.R. Sutherland, A.B. Thomson, L.G. Nilsson, and T. Persson. 2000. Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Inflammatory Bowel Disease 6 (3): 181-187.

Marrie, T.J., C.Y. Lau, S.L. Wheeler, C.J. Wong, and B.G. Feagan. 2000. Predictors of symptom resolution in patients with community-acquired pneumonia. Clinical Infectious Diseases 31 (6): 1362-1367.

Sandborn, W.J., B.G. Feagan, S.B. Hanauer, D.H. Present, L.R. Sutherland, M.A. Kamm, D.C. Wolf, J.P. Baker, C. Hawkey, A. Archambault, C.N. Bernstein, C. Novak, P.K. Heath, S.R. Targan, and CDP571 Crohn's Disease Study Group. 2001. An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology 120 (6): 1330-1338.

Schreiber, S., M. Campieri, J.F. Colombel, S.J. van Deventer, B.G. Feagan, R. Fedorak, and A. Forbes. 2001. Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. International Journal of Colorectal Disease 16 (1): 1-11.
 
 

FELDMAN, R.D.

Tan, C.M., D.J. Kelvin, D.W. Litchfield, S.S.G. Ferguson, and R.D. Feldman. 2001. Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry 40 (6): 1702-1709.
 
 

FERGUSON, K.A.

Bradley, T. 2001. Rationale and design of the Canadian continuous positive airway pressure trial for congestive heart failure patients with central sleep apnea –CANPAP. Canadian Journal of Cardiology 17: 677-84.

Burns, K.E., K.A. Ferguson, A. Spouge, and J.E. Brown. 2001. Massive congenital coronary arteriovenous malformation presenting with exertional dyspnea and desaturation in an adult: a case report and review of the literature. Canadian Journal of Cardiology 17 (1): 85-89.

Ferguson, K.A. 2001. Oral appliance therapy for obstructive sleep apnea: Finally evidence you can sink your teeth into. American Journal of Respiratory and Critical Care Medicine 163 (5): 1294-1295.
 
 

FINNIE, K.J.C.

Finnie, K.J.C., and L.J. Melendez. 2001. 12 lead ECG. Canadian Journal of Diagnosis 18 (2): 63-64.

Finnie, K.J.C., and L.J. Melendez. 2001. Concealed and revealed. Canadian Journal of Diagnosis 19 (1): 61-62.

Finnie, K.J.C., and L.J. Melendez. 2001. A moving target. Canadian Journal of Diagnosis 19 (6): 69-71.

Finnie, K.J.C., and L.J. Melendez. 2001. A palpitating cardiomyopathy. Canadian Journal of Diagnosis 19 (3): 59-60.

Finnie, K.J.C., and L.J. Melendez. 2000. Paroxysmal palpitations. Canadian Journal of Diagnosis 18 (8): 52-53.

Finnie, K.J.C., and L.J. Melendez. 2000. An unusual injury pattern. Canadian Journal of Diagnosis 18 (12): 67-68.

Finnie, K.J.C., and L.J. Melendez. 2000. What is an appropriate response? Canadian Journal of Diagnosis 18 (11): 69-70.

Melendez, L.J., and K.J.C. Finnie. 2001. Arrhythmia in a patient with chest pain. Canadian Journal of Diagnosis 18 (5): 73-74.

Melendez, L.J., and K.J.C. Finnie. 2000. Bradycardia. Canadian Journal of Diagnosis 18 (10): 71-72.

Melendez, L.J., and K.J.C. Finnie. 2001. Chest pain and tachycardia. Canadian Journal of Diagnosis 19 (11): 61-62.

Melendez, L.J., and K.J.C. Finnie. 2001. Deciphering the rhythm. Canadian Journal of Diagnosis 19 (7): 55-56.

Melendez, L.J., and K.J.C. Finnie. 2001. From mild to worse. Canadian Journal of Diagnosis 19 (9): 63-67.

Melendez, L.J., and K.J.C. Finnie. 2001. Keeping the pace. Canadian Journal of Diagnosis 19 (12): 59-60.

Melendez, L.J., and K.J.C. Finnie. 2001. A patient with shortness of breath. Canadian Journal of Diagnosis 19 (10): 64-65.

Melendez, L.J., and K.J.C. Finnie. 2001. A sudden and conspicuous change. Canadian Journal of Diagnosis 19 (4): 71-72.

Melendez, L.J., and K.J.C. Finnie. 2001. Syncope. Canadian Journal of Diagnosis 19 (8): 63-64.

Melendez, L.J., and K.J.C. Finnie. 2000. Tachycardia. Canadian Journal of Diagnosis 18 (9): 64-65.

Melendez, L.J., and K.J.C. Finnie. 2000. The Wandering QRS. Canadian Journal of Diagnosis 18 (7): 51-52.
 
 

FRAHER, L.J.

Whitfield, J.F., P. Morley, L.J. Fraher, A.B. Hodsman, D.W. Holdsworth, P.H. Watson, G.E. Willick, J.-R. Barbier, M. Gulam, R.J. Isaacs, S. MacLean, and V. Ross. 2000. The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu27]cyclo(Glu22-Lys26)hPTH-(1-31)NH2, and hPTH-(1-30)NH2. Calcified Tissue International 66 (4): 307-312.

Yao, L.-J., S. Samuelson, L. Fraher, P. Borron, R.A.W. Veldhuizen, J.L. Malloy, L.A. McCaig, and J.F. Lewis. 2001. Effects of alveolar surfactant aggregates on T-lymphocyte proliferation. Biochimica Et Biophysica Acta 1535 (3): 266-274.
 
 

GEORGE, C.F.P.

George, C.F. 2000. Perspectives on the management of insomnia in patients with chronic respiratory disorders. Sleep 23 (Suppl 1): S31-S35.

George, C.F.P. 2000. Vigilance impairment: assessment by driving simulators. Sleep 23 (supplement): S115-S118.
 
 

GREGOR, J.C.

Gregor, J.C. 2000. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis. American Journal of Managed Care 6: 934-935.
 
 

HARTH, M.

Harth, M. 2000. The aches and pains of Fibromyalgia. A frustrating syndrome. Canadian Journal of Diagnosis 17: 94-104.

White, K.P., and M. Harth. 2001. Classification, Epidemiology and Natural History of Fibromyalgia. Current Pain and Headache Reports 5 (4): 320-329.

White, K.P., and M. Harth. 2001. Lumbar pannus presenting as cauda equina syndrome in a patient with longstanding rheumatoid arthritis. The Journal of Rheumatology 28: 627-30.

White, K.P., M. Harth, M. Speechley, and T. Ostbye. 2000. A general population study of Fibromyalgia tender points in non-institutionalized adults with chronic widespread pain. Journal of Rheumatology 27: 2677-2682.
 
 

HEGELE, R.A.

Anand, S.S., S. Yusuf, V. Vuksan, S. Devanesen, K.K. Teo, P.A. Montague, L. Kelemen, C. Yi, and E. Lonn. 2000. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Lancet 356: 279-284.

Anand, S.S., S. Yusuf, V. Vuksan, S. Devansen, K.K. Teo, P.A. Montague, L. Kelemen, C. Yi, and E. Lonn. 2000. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Indian Heart Journal 52: S35-43.

Busch, C.P., and R.A. Hegele. 2000. Variation of candidate genes in triglyceride metabolism. Journal of Cardiovascular Risk 7 (5): 309-315.

Cao, H., and R.A. Hegele. 2000. Human aryl hydrocarbon receptor nuclear translocator gene (ARNT) d/N511 polymorphism. Journal of Human Genetics 45: 92-93.

Cao, H., and R.A. Hegele. 2000. Human C-reactive protein (CRP) 1059G/C polymorphism. Journal of Human Genetics 45: 100-101.

Cao, H., and R.A. Hegele. 2000. Human cathepsin S gene (CTSS) promoter - 25G/A polymorphism. Journal of Human Genetics 45: 94-95.

Cao, H., and R.A. Hegele. 2000. Human hepatocyte nuclear factor - 1beta (HNF1B) 1968A/G polymorphism. Journal of Human Genetics 45: 98-99.

Cao, H., and R.A. Hegele. 2000. Nuclear lamin A/C R482Q mutation in Canadian Kindreds with Dunnigan-type familial partial lipodystrophy. Human Molecular Genetics 9: 109-112.

Fanella, S., S.B. Harris, T.K. Young, A.J.G. Hanley, B. Zinman, P.W. Connelly, and R.A. Hegele. 2000. Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian Aboriginal poulations. Clinical Chemistry and Laboratory Medicine 38: 413-420.

Feldman, R.D., and R.A. Hegele. 2000. G-protein polymorphisms and maternal/neonatal metabolism: still a weight for the answer. Lancet 355: 1201-1202.

Fisman, M., K. Rabheru, RA. Hegele, V. Sharma, D. Fisman, M. Doering, and J. Appell. 2001. Apolipoprotein E polymorphism and response to electroconvulsive therapy. Journal of ECT 17 (1): 11-14.

Hegele, R.A. 2000. The envelope please: Nuclear lamins and disease. Nature Medicine 6: 136-137.

Hegele, R.A. 2001. Evidence for expanded clinical utility of statin drugs. Current Atherosclerosis Reports 3 (3): 189-190.

Hegele, R.A. 2001. Familial Partial Lipodystrophy: A monogenic form of the insulin resistance syndrome. Mol Genet Metab 71: 539-544.

Hegele, R.A. 2001. Genes and environment in Type 2 Diabetes and atherosclerosis in aboriginal Canadians. Current Atherosclerosis Reports 3 (3): 216-221.

Hegele, R.A. 2000. Insulin Resistance in Human Partial Lipodystrophy. Curr Atheroscler Rep 2: 397-404.

Hegele, R.A. 2001. Molecular basis of partial lipodystrophy and prospects for therapy. Trend Molec Med 7 (3): 121-126.

Hegele, R.A. 2001. Premature atherosclerosis associated with monogenic insulin resistance. Circulation 103 (18): 2225-2229.

Hegele, R.A., C.M. Anderson, and H. Cao. 2000. Lamin A/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy. Diabetes Care 23: 258-259.

Hegele, R.A., C.M. Anderson, J. Wang, D.C. Jones, and H. Cao. 2000. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension and diabetes. Genome Research 10: 652-658.

Hegele, R.A., M.R. Ban, C.M. Anderson, and J.D. Spence. 2000. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. Journal of Investigative Medicine 48: 198-202.

Hegele, R.A., H. Cao, C.M. Anderson, and I.M. Hramiak. 2000. Heterogeneity of nuclear lamin A mutations in dunnigan-type familial partial lipodystrophy. Journal of Clinical Endocrinology & Metabolism 85: 3431-3435.

Hegele, R.A., H. Cao, A.J.G. Hanley, B. Zinman, S.B. Harris, and C.M. Anderson. 2000. Clinical utility of HNF1A genotyping for diabetes in Aboriginal Canadians. Diabetes Care 23: 775-778.

Hegele, R.A., H. Cao, S.B. Harris, A.J.G. Hanley, B. Zinman, and P.W. Connelly. 2000. The private hepatocyte nuclear factor - 1a G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 217-222.

Hegele, R.A., H. Cao, S.B. Harris, B. Zinman, A.J.G. Hanley, and C.M. Anderson. 2000. Gender, obesity, hepatic nuclear factor-1a G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree. International Journal of Obesity and Related Metabolic Disorders 8 (24): 1062-1064.

Hegele, R.A., H. Cao, S.B. Harris, B. Zinman, A.J.G. Hanley, and C.M. Anderson. 2000. Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiological Genomics 3 (1): 39-44.

Hegele, R.A., H. Cao, S.B. Harris, B. Zinman, A.J.G. Hanley, and C.M. Anderson. 2000. Peroxisome proliferator activated receptor-y2 P12A and type 2 diabetes in Canadian Oji-Cree. The Journal of Clinical Endocrinology & Metabolism 85: 2014-2019.

Hegele, R.A., H. Cao, M.W. Huff, and C.M. Anderson. 2000. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. The Journal of Clinical Endocrinology & Metabolism 85: 3089-3093.

Hegele, R.A., A.J.G. Hanley, B. Zinman, S.B. Harris, and C.M. Anderson. 2000. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree. Journal of Human Genetics 45: 184-187.

Hegele, R.A., M. Huff, and K. Young. 2001. Common genomic variation in LMNA modulates indexes of obesity in Inuit. Journal of Clinical Endocrinology and Metabolism 86 (6): 2747-2751.

Hegele, R.A., K. Kwan, SB. Harris, A.J.G. Hanley, B. Zinman, and H. Cao. 2000. NAT2 polymorphism associated with plasma glucose concentration in Canadian Oji-Cree. Pharmacogenetics 10: 233-238.

Hegele, R.A., J. Wang, S.B. Harris, J.H. Brunt, T.K. Young, A.J.G. Hanley, B. Zinman, P.W. Connelly, and C.M. Anderson. 2001. Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 154 (3): 579-587.

Hegele, R.A., J. Yuen, and H. Cao. 2001. Single nucleotide polymorphisms of the lamina proteome. Journal of Human Genetics 46 (6): 351-354.

Hegele RA. 2000. Angiotensin-converting enzyme (ACE) inhibition in the secondary prevention of vascular disease: the Heart Outcomes Prevention Evaluation (HOPE) Trial and its substudies. Curr Atheroscler Rep 2: 361-362.

Krahn, A.D., J. Wang, B. Spindler, A.C. Skanes, R. Yee, G.J. Klein, and R.A. Hegele. 2000. A novel mutation in KVLQT1, L122P, found in a family with autosomal doinant long QT syndrome. American Heart Journal 140: 146-149.

Miner, S.E., R.A. Hegele, J. Sparkes, J.M. Teitel, K.A. Bowman, P.W. Connelly, H. Benjamali, H.K. Lau, R.J. Chisholm, S. Babaei, and B.H. Strauss. 2000. Homocysteine, lipoprotein(a), and restinosis after percutaneous transluminal coronary angioplasty: a prospective study. American Heart Journal 140: 272-278.

Wang, J., J.R. Burnett, S. Near, K. Young, B. Zinman, A.J.G. Hanley, P.W. Connelly, S.B. Harris, and R.A. Hegele. 2000. Common and rare ABCA1 variants affecting plasma high density lipoprotein cholesterol. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 1983-1989.

Wang, J., and R.A. Hegele. 2000. Microsomal triglyceride transfer protein (MTP) gene mutations in Canadian subjects with abetalipoproteinemia. Human Mutation 15: 294-295.
 
 

HODSMAN, A.B.

Crilly, R.G., R.J. Sebaldt, A.B. Hodsman, J.D. Adachi, J.P. Brown, C. Goldsmith, D.A. Hanley, and W. Olszynski. 2000. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial response in patients with osteoporosis. Osteoporosis International 11: 607-614.

Hodsworth, D.W., M. Thornton, D. Drost, P.H. Watson, L.J. Fraher, and A.B. Hodsman. 2000. Rapid small animal DEXA using digital radiography. Journal of Bone and Mineral Research 15: 2451-2457.
 
 

HOUSE, A.A.

Cil, T., I.S. Tummon, A.A. House, B. Taylor, G. Hooker, J. Franklin, R. Rankin, and M. Carey. 2000. A Tale of Two Syndromes: Ovarian Hyperstimulation and Abdominal Compartment. Human Reproduction 15 (5): 1058-60.

House, A.A., G.A. Wells, J.G. Donnelly, S.P. Nadler, and P.C. Hébert. 2000. Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids. Nephrology Dialysis Transplantation 15 (7): 1029-1034.
 
 

HRAMIAK, I.M.

Brill-Edwards, P., L. Coutoure, G. Evans, P. Hamilton, I. Hramiak, D. Megran, M.L. Schmuck, G. Cole, N. Mikhael, and G. Normal. 2001. Predicting performance on the royal college of physicians and surgeons of Canada internal medicine written examination. Canadian Medical Association Journal 165: 1305-1307.

The DCCT Research Group (including Hramiak, I.M.). 2000. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 23: 1084-1091.

The Heart-Outcomes Prevention Evaluation (HOPE) Study Investigators (including I.M. Hramiak). 2000. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients. New England Journal of Medicine 342: 145-153.

The Heart Outcomes Prevention (HOPE) Study Investigtors (including I.M. Hramiak). 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. New England Journal of Medicine 342: 154-160.

Hegele, R.A., H. Cao, C.M. Anderson, and I.M. Hramiak. 2000. Heterogeneity of nuclear lamin A mutations in dunnigan-type familial partial lipodystrophy. Journal of Clinical Endocrinology & Metabolism 85: 3431-3435.

Yale, J.-F., T.R. Valiquett, M.N. Ghazzi, JK. Owens-Grillo, R.W. Whitcomb, and H.L. Foyt for the Triglitazone Triple-Therapy Study Group (including I.M. Hramiak). 2001. The effect of a thiazolicinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. Annals of Internal Medicine 134 (9pt1): 737-745.
 
 

HUMEN, D.

Warburton, D.E.R., R.C. Welsh, M.J. Haykowski, D.A. Taylor, and D.P. Humen. 2000. Effects of Half-Ironman competition on the development of late potentials. Medicine and Science in Sports and Exercise 32 (7): 1208-13.

Zalai, C.V., M.D. Kolodziejczyk, L. Pilrski, A. Christov, P.N. Nation, M. Lundstorm-Hobman, W. Tymchak, V. Dzavic, D. Humen, W. Kostuk, G. Jablonsky, P. Pflugfelder, and L.A. Brown. 2001. Increased circulating monocyte activation in patients with unstable coronary syndromes. Journal of the American College of Cardiology 38 (5): 1340-1347.
 
 

HURWITZ, J.S.

Hurwitz, J.S. 2001. Understanding Tremor in the Elderly. Canadian Journal of Diagnosis 18 (April): 99-107.
 
 

JABLONSKY, G.

Boyd, W.D., B. Kiaii, K. Kodera, R. Rayman, W. abu-Khudair, S. Fazel, W.B. Dobkowski, S. Ganapathy, G. Jablonsky, and R.J. Novick. 2001. Early Experience with Robotic Assisted Internal Thoracic Artery Harvest. SLEPT: Surg Laparoscopy Endoscopy & Percutaneous Techniques 01 (1): 168.

Boyd, W.D., R. Rayman, N.D. Desai, A.H. Menkis, W. Dobkowski, S. Ganapathy, B. Kiaii, and G. Jablonsky. 2000. Closed Chest coronary Artery Bypass Grafting on the Beating Heart Using a Computer-Enchanced Surgical Robotic System. The Journal of Thoracic and Cardiovascular Surgery 120 (4): 807-809.

Zalai, C.V., M.D. Kolodziejczyk, L. Pilrski, A. Christov, P.N. Nation, M. Lundstorm-Hobman, W. Tymchak, V. Dzavic, D. Humen, W. Kostuk, G. Jablonsky, P. Pflugfelder, and L.A. Brown. 2001. Increased circulating monocyte activation in patients with unstable coronary syndromes. Journal of the American College of Cardiology 38 (5): 1340-1347.
 
 

JEVNIKAR, A.M.

Gao, J.-X., J. Zhang, C. Awaraji, M. Bhatia, A.M. Jevnikar, B. Singh, D. Bell, and T.L. Delovitch. 2000. Preferential Proliferation and Differentiation of Double-Positive Thymocytes into CD8+ Single-Positive Thymocytes in a Novel Cell Culture Medium. Cell Immunology 202 (1): 41-53.

Kellersmann, R., R. Zhong, D. Grant, B. Garcia, A. Blomer, W. Liu, N. Wagner, W. Muller, A. Jevnikar, A. Thiede, and A. Lazarovits. 2000. Despite high levels of lymphocyte homing receptor alpha4beta7 integrin after small bowel allotransplantation, it is not critical for rejection. Transplantation Proceedings 32 (6): 1267-1268.

Ma, S., and A.M. Jevnikar. 2000. Production of autoantigens in plants for oral immunotherapy of autoimmune diseases. Dev. Plant Genetics and Breeding 5: 239-248.

McLaughlin, K., K.S. Rizkalla, P.C. Adams, D.R. Grant, W.J. Wall, A.M. Jevnikar, and P.J. Marotta. 2000. Hepatitis C infection is not associated with an increased risk of acute liver allograft rejection. Transplantation Proceedings 32 (8): 2814-2816.

McLaughlin, K., S. Wajstaub, P.J. Marotta, P.C. Adams, D.R. Grant, W.J. Wall, A.M. Jevnikar, and K.S. Rizkalla. 2000. Increased risk for post-transplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transplantation 6 (5): 570-574.

Noorchashm, H., D.J. Moore, L.E. Noto, N. Noorchashm, A.J. Reed, A.L. Reed, H.K. Song, R. Mozaffari, A.M. Jevnikar, C.F. Barker, and A. Naji. 2000. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in non-obese diabetic (NOD) mice. Journal of Immunology 165 (8): 4685-4696.
 
 

KHALIL, M.W.

Handoko, K., K. Yang, B. Strutt, M.W. Khalil, and D.W. Killinger. 2000. The regulation of 11-B HSD activity and gene expression by TNF and insulin in human adipose stromal cells. The Journal of Steroid Biochemistry and Molecular Biology 72: 163-168.
 
 

KLEIN, G.J.

Chauhan, V.S., A.D. Krahn, G.J. Klein, A.C. Skanes, and R. Yee. 2001. Supraventricular tachycardia. Medical Clinics of North America 85 (2): 193-223.

Humphries, K.H., C.R. Kerr, S.J. Connolly, G. Klein, JA. Boone, M. Green, R. Sheldon, M. Talajic, P. Dorian, and D. Newman. 2001. New-onset atrial fibrillation: Sex differences in presentation, treatment, and outcome. Circulation 103: 2365-2370.

Klein, G.J., A.D. Krahn, R. Yee, and A.C. Skanes. 2000. The implantable loop recorder: The herald of a new age of implantable monitors. PACE 23: 1456.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. The predictive value of presyncope in patients monitored for assessment of syncope. American Heart Journal 141 (5): 817-821.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Randomized assessment of syncope trial: Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104: 46-51.

Krahn, A.D., P. Nyugen-Ho, G.J. Klein, R. Yee, A.C. Skanes, and N. Suskin. 2001. QT dispersion: An electrocardiographic derivative of QT prolongation. American Heart Journal 141 (1): 111-116.

Krahn, A.D., S.M. Renner, G.J. Klein, R. Yee, A. Skanes, and E.M. Evans. 2000. The utility of holter monitoring compared to loop recorders in the evaluation of syncope and presyncope. Annals of Noninvasive Electrocardiology 5 (3): 284-289.

Lee, JK., GJ. Klein, AD. Krahn, R. Yee, K. Zarnke, C. Simpson, A. Skanes, and B. Spindler. 2000. Rate control versus conversion strategy in postoperative atrial fibrillation: a prospective randomized pilot study. American Heart Journal 140 (6): 871-877.

LeLorier, P., G.J. Klein, A. Krahn, R. Yee, and A. Skanes. 2001. Should patients with asymptomatic Wolff-Parkinson-White pattern undergo a catheter ablation. Current Cardiology Reports : 301-304.

Simpson, C.S., G.J. Klein, FJ. Brennan, A.D. Krahn, R. Yee, and A.C. Skanes. 2000. Impact of a mandatory physician reporting system for cardiac patients potentially unfit to drive. Canadian Journal of Cardiolovy 16 (10): 1257-1263.

Simpson, C.S., G.J. Klein, and B. Hoffmaster. 2000. Expensive medical techologies and indication extrapolation: The case of implantable cardioverter defibrillators. American Heart Journal 140 (3): 419-422.

Simpson, C.S., R. Yee, J.K. Lee, M. Braney, G.J. Klein, A.D. Krahn, and A.C. Skanes. 2001. Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. American Heart Journal 142 (2): 294-300.

Skanes, A.C., M. Dubuc, G.J. Klein, B. Thibault, A.D. Krahn, R. Yee, D. Roy, P. Guerra, and M. Talajic. 2000. Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation 102 (13): 2856-2860.

Skanes, A.C., A.D. Krahn, R. Yee, G.J. Klein, S.J. Connolly, C.R. Kerr, M. Gent, K.E. Thorpe, R.S. Roberts, and for the CTOPP Investigators. 2001. Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing. Journal of the American College of Cardiology 38 (1): 167-172.

Skanes, A.C., R. Yee, A.D. Krahn, and G.J. Klein. 2001. Should ablative therapy be first-line therapy for idiopathic atrial fibrillation? Journal of Invasive Cardiology 13 (7): 563-568.
 
 

KORTAS, C.

Clark, W.F., C. Kortas, A.P. Heidenheim, J. Garland, E. Spanner, and A. Parbtani. 2001. Flaxseed in Lupus Nephritis: A two year nonplacebo-controlled Study. Journal of the American College of Nutrition 20: 143-148.

Lindsay, R.M., A.P. Heidenheim, R. Leitch, H. Ryan, A. Kroeker, K. Peters, L. Workentin, G. Nesrallah, S. Prakash, and C. Kortas. 2001. Short daily versus long nocturnal hemodialysis. ASAIO Journal 47 (5): 449-455.

Lindsay, R.M., C. Kortas, and Daily/Nocturnal Dialysis Study group. 2001. Hemeral [daily] hemodialysis. Advances in Renal Replacement Therapy 8 (4): 236-249.
 
 

KOSTUK, W.J.

Baran, K.W., M. Nguyen, G.R. McKendall, C.T. Lambrew, G. Dykstra, S.T. Palmeri, R.J. Gibbons, S. Borzak, B.E. Sobel, S.G. Goulay, A.C. Rundle, C.M. Gibson, and H.V. Barronfor the LIMIT AMI Investigators (Kostuk WJ). 2001. Double-blind, randomized trial of an anti-CD 18 antibody in conjunction with recombinant tissue plasminogen activator for aute myocardial infarction. Circulation 104: 2778-2782.

Cure Study Investigators (Kostuk, W.J.). 2000. The clopidogrel in unstable angina to prevent recurrent Events (CURE) trial programme. European Heart Journal 21: 2033-2041.

The ESPRIT Investigators (Kostuk, W,J,). 2000. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 345: 2037-2044.

Kostuk, W.J. 2001. Alternative Cardiovascular Medical Therapies. Cardiology. 1st ed. M.H. Crawford, and J.P. DiMarco. British Library Cataloguing in Publication Data: Mosby. 17.1-17.8.

Kostuk, W.J. 2001. Congestive heart failure: what can we offer our patients? Canadian Medical Association 165 (8): 1053-1055.

Zalai, C.V., M.D. Kolodziejczyk, L. Pilrski, A. Christov, P.N. Nation, M. Lundstorm-Hobman, W. Tymchak, V. Dzavic, D. Humen, W. Kostuk, G. Jablonsky, P. Pflugfelder, and L.A. Brown. 2001. Increased circulating monocyte activation in patients with unstable coronary syndromes. Journal of the American College of Cardiology 38 (5): 1340-1347.
 
 

KOVACS, M.J.

Bates S. M., Grand'Maison A., Johnston M., Kovacs M. J., Naguit I., and Ginsberg J. S. 2001. A latex d-dimer reliably excludes venous thromboembolism. Archives of Internal Medicine (161): 447-453.

Brill-Edwards, P., J. Ginsberg, M. Gent, J. Hirsh, R. Burrows, C. Kearon, W. Geerts, M. Kovacs, J. Weitz, K.S. Robinson, R. Whittom, and G. Couture. 2000. Safety of withholding antepartum heparin in women with a previous episode of venous thromboembolism. New England Journal of Medicine (343): 1439-1444.

Crowther, M.A., J. Julian, D. McCarty, J. Douketis, M. Kovacs, L. Biagoni, T. Schnurr, J. McGinnis, M. Gent, J. Hirst, and J. Ginsberg. 2000. Treatment of excessive anticoagulation due to Warfarin with oral vitamin K: A randomized controlled trial. Lancet 356: 1551-1553.

Kovacs, M.J., K. MacKinnon, D. Anderson, K. O'Rourke, M. Keeney, C. Kearon, J. Ginsberg, and P.S. Wells. 2001. A Comparison of Three Sensitive Rapid D-Dimer Methods for the Diagnosis of Venous Thromboembolism. British Journal of Haematology 115 (1): 140-144.

Luk, C., P.S. Wells, D. Anderson, and M.J. Kovacs. 2001. Extended Outpatient Therapy with Low Molecular Weight Heparin for the Treatment of Recurrent Venous Thromboembolism Despite Warfarin Therapy. American Journal of Medicine. 4 (111): 270-273.

Teefy, A.M., J. Martin, and M.J. Kovacs. 2000. Warfarin Resistance Due to Sulfasalazine. Annals of Pharmacotherapy (November): 1265-1268.

Tinmouth, A., B.H. Morrow, M.K. Cruickshank, P.M. Moore, and M.J. Kovacs. 2001. Dalteparin As Peri-procedure Anticoagulation For Patients On Warfarin and At High Risk Of Thrombosis. Annals of Pharmacotherapy 6 (35): 669-674.

Wells, P.A., D.R. Anderson, M. Rodger, I. Stiell, Dreyer J.F., Barnes D., Forgie M., Kovacs G., Ward J., and M.J. Kovacs. 2001. Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and D-Dimer. Annals of Internal Medicine 2 (135): 98-107.
 
 

KRAHN, A.D.

Klein, G.J., A.D. Krahn, R. Yee, and A.C. Skanes. 2000. The implantable loop recorder: The herald of a new age of implantable monitors. PACE 23: 1456.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. The predictive value of presyncope in patients monitored for assessment of syncope. American Heart Journal 141 (5): 817-821.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Randomized assessment of syncope trial: Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104: 46-51.

Krahn, A.D., P. Nyugen-Ho, G.J. Klein, R. Yee, A.C. Skanes, and N. Suskin. 2001. QT dispersion: An electrocardiographic derivative of QT prolongation. American Heart Journal 141 (1): 111-116.

Lee, JK., GJ. Klein, AD. Krahn, R. Yee, K. Zarnke, C. Simpson, A. Skanes, and B. Spindler. 2000. Rate control versus conversion strategy in postoperative atrial fibrillation: a prospective randomized pilot study. American Heart Journal 140 (6): 871-877.

Seidl, K., M. Rameken, S. Breunung, J. Senges, W. Jung, D. Andersen, A. van Toor, A.D. Krahn, and G.J. Klein Reveal Investigators. 2000. Diagnostic assessment of recurrent unexplained syncope with a new subcutaneouslyy implantable loop recorder. Europace 2 (3): 256-262.

Simpson, C.S., R. Yee, J.K. Lee, M. Braney, G.J. Klein, A.D. Krahn, and A.C. Skanes. 2001. Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. American Heart Journal 142 (2): 294-300.

Skanes, A.C., M. Dubuc, G.J. Klein, B. Thibault, A.D. Krahn, R. Yee, D. Roy, P. Guerra, and M. Talajic. 2000. Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation 102 (13): 2856-2860.

Skanes, A.C., R. Yee, A.D. Krahn, and G.J. Klein. 2001. Should ablative therapy be first-line therapy for idiopathic atrial fibrillation? Journal of Invasive Cardiology 13 (7): 563-568.
 
 

LAURIER, L.G.

Preiksaitis, H.G., P.S. Krysiak, T. Chrones, V. Rajgopal, and L.G. Laurier. 2000. Pharmacological and molecular characterization of muscarinic receptor subtypes in human esophageal smooth muscle. Journal of Pharmacology and Experimental Therapeutics 295 (3): 879-88.

Wang, J., P.S. Krysiak, L.G. Laurier, S.M. Sims, and H.G. Preiksaitis. 2000. Human esophageal smooth muscle cells express muscarinic receptor subtypes M(1) through M(5). American Journal of Physiology- Gastrointestinal and Liver Physiology 279: G1059-1069.
 
 

LEWIS, J.F.

Brackenbury, A., P. Puligandla, L. McCaig, V. Nikore, L.J. Yao, R. Veldhuizen, and J.F. Lewis. 2001. Evaluation of exogenous surfactant in HCl-induced lung injury. American Journal of Respiratory and Critical Care Medicine 163 (5): 1135-1142.

Kerr, C., R. Veldhuizen, and J.F. Lewis. 2001. Effects of high frequency oscillation on alveolar surfactant aggregates in an acute lung injury model. American Journal of Respiratory and Critical Care Medicine 164: 237-242.

Lewis, J.F. 2000. Surfactant alterations in ARDS and pneumonia. International Congress: Surfactant 2000 Applied Cardiopulmonary Pathophysiology. B. Lachmann, and L.M.G. van Golde. 9 (3). 265.

Malloy, J., R. Veldhuizen, and J.F. Lewis. 2000. Pulmonary inflammation and surfactant alterations in the development of sepsis. International Congress: Surfactant 2000 9 (3): 270.

Nakamura, T., R. Veldhuizen, L.-J. Yao, L. McCaig, J.F. Lewis, and J. Malloy. 2001. Mechanical ventilation of isolated septic rat lungs: effects on surfactant and inflammatory cytokines. Journal of Applied Physiology 91 (2): 811-820.

Ribeiro, S.P., K. Rhee, L.N. Tremblay, R. Veldhuizen, J.F. Lewis, and A.S. Slutsky. 2001. Heat stress attenuates ventilatory-induced lung dysfunction in an ex vivo rat lung model. American Journal of Respiratory and Critical Care Medicine 163 (6): 1451-1456.

Spragg, R., and J.F. Lewis. 2000. Pathology of the Surfactant System of the Mature Lung. Applied Cardiopulmonary Pathophysiology 9 (3): 177. 2nd San Diego Conference: Full Report.

Spragg, R., and J.F. Lewis. 2001. Pathology of the Surfactant System of the Mature Lung: 2. American Journal of Respiratory and Critical Care Medicine 9 (3): 177. 2nd San Diego Conference: Full Report.

Spragg, R., J.F. Lewis, W. Wurst, and F. Rathgeb. 2000. First clinical and early clinical experience with a recombinant SP-C based surfactant. International Congress: Surfactant 2000 Applied Cardiopulmonary Pathophysiology 9 (3): 301.

Yao, L.J., L. Fraher, R. Veldhuizen, S. Samuelson, P. Borron, J. Malloy, L. McCaig, and J.F. Lewis. 2001. Effects of surfactant aggregates on T lymphocyte proliferation. Biochimica Et Biophysica Acta 1535: 266-274.
 
 

LINDSAY, R.M.

Cohen, B.A., A. Heidenehim, S. Seiler, and R.M. Lindsay. 2000. Therapy of iron deficiency with sodium ferric gluconate in hemodialysis patients. Journal of the American Society of Nephrology 11: 261.

Klarenbach, SW., AP. Heidenheim, R. Leitch, R.M. Lindsay, and the Daily/Nocturnal Dialysis Study group. 2000. Reduced requirement for Erythropoietin with quotidian hemodialysis therapy. ASAIO Journal 47 (2): 153.

Lindsay, R.M., A.P. Heidenheim, R. Leitch, H. Ryan, A. Kroeker, K. Peters, L. Workentin, G. Nesrallah, S. Prakash, and C. Kortas. 2001. Short daily versus long nocturnal hemodialysis. ASAIO Journal 47 (5): 449-455.

Lindsay, R.M., C. Kortas, and Daily/Nocturnal Dialysis Study group. 2001. Hemeral [daily] hemodialysis. Advances in Renal Replacement Therapy 8 (4): 236-249.

Lindsay, R.M., and E. Spanner. 2001. Nutritional Management in Peritoneal Dialysis. Dialysis Therapy. 3rd ed. A.R. Nissenson, and R.N. Fine. Philadelphia, USA: Hanley and Belfus. 275-290.

Lindsay, R.M., and J. Sternby. 2001. Future Directions in Dialysis Quantification. Seminars in Dialysis 14 (4): 300-307.

Lindsay, R.M., J. Sternby, B. Olde, R. Persson, M.E. Thatcher, and K. Sargent. 2000. The measuremernt of access blood flow [Qa] using an on-line dialysate urea monitor. Journal of the American Society of Nephrology 11: 188.

Lindsay, R.M., J. Sternby, B. Olde, R. Persson, M.E. Thatcher, and K. Sargent. 2000. The pre-dialysis urea concentration can be accurately estimated without blood sampling. Journal of the American Society of Nephrology 11: 323.

Lindsay, RM., B. Bene, N. Goux, AP. Heidenheim, C. Landgren, and J. Sternby. 2001. Relationship between effective ionic dialysance and in-vivo clearance during hemodialysis. American Journal of Kidney Diseases 38 (3): 565-574.

Perez, R.A., P.G. Blake, E. Spanner, M. Patel, S. McMurray, P. Heidenheim, and R.M. Lindsay. 2000. High creatinine excretion ratio predicts a good outcome in peritoneal dialysis patients. American Journal of Kidney Diseases 36 (2): 362-367.

Perez, R.A., P.G. Blake, E. Spanner, M. Patel, S. McMurray, P. Heidenheim, and R.M. Lindsay. 2000. High creatinine excretion ratio predicts a good outcome in peritoneal dialysis patients. American Journal of Kidney Diseases 36 (2): 362-367.

Shulman, TS., A.P. Heidenheim, S.M. Shulman, and R.M. Lindsay. 2001. Preserving central blood volume [CBV]: Changes in body fluid compartment during hemodialysis. ASAIO Journal 47 (2): 153.
 
 

MAHON, J.L.

Jakobi, J.M., D.W. Killinger, B.M. Wolfe, J.L. Mahon, and C.L. Rice. 2001. Quadriceps muscle function and fatigue in women with Addison's disease. Muscle & Nerve 24: 1040-1049.
 
 

MAROTTA, P.J.

Marotta, P.J., I.W. Graziadei, and C.N. Ghent. 2000. Muscle Cramps: A 'complication' of cirrhosis. Canadian Journal of Gastroenterology 14: 555555.

Marotta, P.J., J.C. Gregor, P.C. Adams, C.N. Ghent, and B.G. Feagan. 2001. Utility Measurements Achieve Accurate Patient-Derived HRQOL Scores: The Disutility is Equal in Hepatitis C Patients Compared with other Chronic Liver Diseases. Hepatology 32 (4): 1731A.

McLaughlin, K., S. Wajstaub, P.J. Marotta, P.C. Adams, D.R. Grant, W.J. Wall, A.M. Jevnikar, and K.S. Rizkalla. 2000. Increased risk for post-transplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transplantation 6 (5): 570-574.

Myers, R.P., D. Downey, S. Chakrabarti, and P.J. Marotta. 2001. Multiple Focal Nodular Hyperplasia and Steatohepatitis: Atypical Imaging Characteristics. Canadian Journal of Gastroenterology 15 (2): 137-142.
 
 

MASSEL, D.R.

Huynh, T., D.R. Massel, S. Matheson, D. Davies, J. Cox, and P. Daly. 2000. AMI cardiac care unit mortality in Canada:higher among women. Results from FASTRAK - a national registry. Canadian Journal of Cardiology 16 (suppl B): 39B.

Huynh, T., D.R. Massel, S. Matheson, D. Davies, J. Cox, and P. Daly. 2000. Complications related to AMI and reperfusion: hazard for women? Results from FASTRAK - a national database. Canadian Journal of Cardiology 16 (suppl B): 34B.

Huynh, T., D.R. Massel, S. Matheson, D. Davies, J. Cox, and P. Daly. 2000. Is there a bias against women and the elderly when it comes to more effective reperfusion strategies in AMI? Canadian Journal of Cardiology 16 suppl B: 16B.

Little, S., and D.R. Massel. 2000. Risks and benefits of adding anti-platelet therapy of warfarin among patients with prosthetic heart valves: a meta-analysis. Journal of the American College of Cardiology 35 (suppl A): 532a.

Massel, D.R., and M.K. Cruickshank. 2000. Greater expectations in a cancer trial: Absolute more than relative survival increases; community more than academic clinicians. Cancer Investigation 18: 798-803.

Massel, D.R., J.A. Dawdy, and L.J. Melendez. 2000. Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibility. American Heart Journal 140: 221-226.

Massel, D.R., and S.H. Little. 2001. Risks and benefits of adding anti-platelet therapy of warfarin among patients with prosthetic heart valves: a meta-analysis. Journal of the American College of Cardiology 37: 569-578.
 
 

MCCORMACK, D.G.

Baechtold, F., J.A. Scott, M. Markert, S. Mehta, D.G. McCormack, F. Anglada, B. Waeber, and F. Feihl. 2001. Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture? Shock 16: 137-142.

Keenan, S.P., C. Powers, and D.G. McCormack. 2001. Noninvasive ventilation in milder COPD exacerbations: An RCT. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A250.

McCormack, D.G. 2000. Respiratory Disorders: Adult Asthma. Therapeutic Choices. 3rd ed. J. Gray, A.M. Gillis, G.E. Johnson, J.A. Johnson, S.M. MacLeod, J. McCormack, and W. McLean. Canadian Cataloguing in Publication Data. 312-319.

McCormack, D.G., M. Rohan, and S. Mehta. 2001. Role of nitric oxide in leukocyte sequestration in sepsis induced lung injury: Assessment using intravital videomicroscopy. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A815.

Razavi, H.M., L.F. Wang, J.A. Scott, S. Weicker, D.G. McCormack, and S. Mehta. 2001. iNOS in pulmonary inflammatory cells, but not parenchymal cells contributes to pulmonary oxidative injury in septic mice. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A816.

Scott, J.A., M. Duggan, A. Bihari, S. Mehta, and D.G. McCormack. 2001. Functional Inhibition and Down-Regulation of cNOS in Early vs. Late Sepsis. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A457.

Strathopulos, P.B., X. Lu, J.A. Scott, J. Hammond, D.G. McCormack, J.M.O. Arnold, and Q.P. Feng. 2001. Increased L-arginine uptake and inducible nitric oxide activity in the aorta of heart failure rats: Role of L-arginine transport in nitric oxide production. American Journal of Physiology 280 (2): H859-H867.

Wang, L.F., M. Patel, H. Razavi, J.A. Scott, S.W. Weicker, D.G. McCormack, and S. Mehta. 2001. Differential contribution of iNOS in inflammatory vs pulmonary stromal cells to pulmonary edema in septic mice. American Journal of Respiratory and Critical Care Medicine 163 (pt 2): A816.

Wang, L.F., S. Weicker, J.A. Scott, M. Joseph, G.T. De Sanctis, H.M. Razavi, S. Mehta, and D.G. McCormack. 2001. Relative contribution of hemopoietic and pulmonary parenchymal cells to lung inducible nitric oxide synthase (iNOS) activity in murine endotoxemia. Biochemical and Biophysical Research Communications 283 (3): 694-699.

Weicker, S., T. Karachi, J.A. Scott, D.G. McCormack, and S. Mehta. 2001. Non-invasive measurement of exhaled NO in a single, spontaneously breathing mouse. American Journal of Respiratory and Critical Care Medicine 163 (5): 1113-1116.

Weicker, S.W., A.D. Dukelow, H.M. Razavi, L.F. Wang, D.G. McCormack, and S. Mehta. 2001. Role of nitric oxide in host defense during acute murine Pseudomonas pneumonia. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A382.

Yaghi, A., J.A. Bradbury, D.C. Zeldin, S. Mehta, and D.G. McCormack. 2001. Cytochrome P450 CYP2J4 is reduced in a rat model of acute Pseudomonas pneumonia. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A396.

Yaghi, A., D.G. McCormack, J. Bend, J.A. Scott, and S. Mehta. 2001. Cytochrome P450 (CYP) Metabolites of Arachidonic Acid But Not Cyclooxygenase-2 (COX-2) Metabolites Contribute To The Pulmonary Vascular Hyporeactivity in Rats With Acute Pseudomonas Pneumonia. Journal of Pharmacology and Experimental Therapeutics 297 (2): 479-488.

Yaghi, A., S. Mehta, and D.G. McCormack. 2001. Delayed rectifier potassium channels (Kv) contribute to the depressed pulmonary vascular contractility in acute Pseudomonas pneumonia. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A396.
 
 

MCMANUS, R.M.

Chiasson, J.-L., L. Naditch, and Miglitol Canadian university investigator group. 2001. The synergistic effect of miglitol plous petformin combination therapy in the treatment of Type 2 diabetes. Diabetes Care 24 (6): 989-994. (R.M. McManus participated as local investigator).

McManus, R., Y. BoAbbas, H. Lampe, R. Holliday, and D. Shum. 2000. Maxillary giant cell granlumona, pheochromocytoma, and hyperparathyroidism without medullary thryoid carcinoma. ENT Journal 79 (8): 590-593.

McManus, R., I. Cunningham, A. Watson, L. Harker, and D.T. Finegood. 2001. Beta Cell function and visceral fat in lactating women with a history of gestational diabetes. Metabolism 50 (6): 715-719.
 
 

MEHTA, S.

Baechtold, F., J.A. Scott, M. Markert, S. Mehta, D.G. McCormack, F. Anglada, B. Waeber, and F. Feihl. 2001. Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture? Shock 16: 137-142.

Bateman, R.M., J. Jagger, M. Sharpe, S. Mehta, and C. Ellis. 2001. Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. American Journal of Physiology-Heart and Circulatory Physiology 280: H2848-2856.

McCormack, D.G., S. Mehta, K. Tyml, R. Potter, and M. Rohan. 2000. Assessment of microvascular diameter, leukocyte sequestration and protein leak in a model of acute lung injury: assessment using intravital. Microvascular Research 60: 131-140.

McCormack, D.G., M. Rohan, and S. Mehta. 2001. Role of nitric oxide in leukocyte sequestration in sepsis induced lung injury: Assessment using intravital videomicroscopy. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A815.

Wang, L.F., S. Weicker, J.A. Scott, M. Joseph, G.T. De Sanctis, H.M. Razavi, S. Mehta, and D.G. McCormack. 2001. Relative contribution of hemopoietic and pulmonary parenchymal cells to lung inducible nitric oxide synthase (iNOS) activity in murine endotoxemia. Biochemical and Biophysical Research Communications 283 (3): 694-699.

Weicker, S., T. Karachi, J. Scott, D.G. McCormack, and S. Mehta. 2001. Non-invasive measurement of exhaled nitric oxide in a spontaneously breathing. American Journal of Respiratory and Critical Care Medicine 163: 1-4.

Weicker, S.W., A.D. Dukelow, H.M. Razavi, L.F. Wang, D.G. McCormack, and S. Mehta. 2001. Role of nitric oxide in host defense during acute murine Pseudomonas pneumonia. American Journal of Respiratory and Critical Care Medicine 163 (5, pt 2): A382.

Werhun, R., and S. Mehta. 2000. Update on Pathogenesis and Therapy of Pulmonary Sarcoidosis. Ontario Thoracic Review 12: 2.

Yaghi, A., C. Webb, J. Scott, S. Mehta, J. Bend, and D. McCormack. 2001. Cytochrome p450 metabolites of acid but not cyclooxygenase-2 metabolites. Journal of Pharmacology and Experimental Therapeutics 297 (2): 479-488.
 
 

MELENDEZ, L.J.

Finnie, K.J.C., and L.J. Melendez. 2001. 12 lead ECG. Canadian Journal of Diagnosis 18 (2): 63-64.

Finnie, K.J.C., and L.J. Melendez. 2001. Concealed and revealed. Canadian Journal of Diagnosis 19 (1): 61-62.

Finnie, K.J.C., and L.J. Melendez. 2001. A moving target. Canadian Journal of Diagnosis 19 (6): 69-71.

Finnie, K.J.C., and L.J. Melendez. 2001. A palpitating cardiomyopathy. Canadian Journal of Diagnosis 19 (3): 59-60.

Finnie, K.J.C., and L.J. Melendez. 2000. Paroxysmal palpitations. Canadian Journal of Diagnosis 18 (8): 52-53.

Finnie, K.J.C., and L.J. Melendez. 2000. An unusual injury pattern. Canadian Journal of Diagnosis 18 (12): 67-68.

Finnie, K.J.C., and L.J. Melendez. 2000. What is an appropriate response? Canadian Journal of Diagnosis 18 (11): 69-70.

Massel, D.R., J.A. Dawdy, and L.J. Melendez. 2000. Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibility. American Heart Journal 140: 221-226.

Melendez, L.J., and K.J.C. Finnie. 2001. Arrhythmia in a patient with chest pain. Canadian Journal of Diagnosis 18 (5): 73-74.

Melendez, L.J., and K.J.C. Finnie. 2000. Bradycardia. Canadian Journal of Diagnosis 18 (10): 71-72.

Melendez, L.J., and K.J.C. Finnie. 2001. Chest pain and tachycardia. Canadian Journal of Diagnosis 19 (11): 61-62.

Melendez, L.J., and K.J.C. Finnie. 2001. Deciphering the rhythm. Canadian Journal of Diagnosis 19 (7): 55-56.

Melendez, L.J., and K.J.C. Finnie. 2001. From mild to worse. Canadian Journal of Diagnosis 19 (9): 63-67.

Melendez, L.J., and K.J.C. Finnie. 2001. Keeping the pace. Canadian Journal of Diagnosis 19 (12): 59-60.

Melendez, L.J., and K.J.C. Finnie. 2001. A patient with shortness of breath. Canadian Journal of Diagnosis 19 (10): 64-65.

Melendez, L.J., and K.J.C. Finnie. 2001. A sudden and conspicuous change. Canadian Journal of Diagnosis 19 (4): 71-72.

Melendez, L.J., and K.J.C. Finnie. 2001. Syncope. Canadian Journal of Diagnosis 19 (8): 63-64.

Melendez, L.J., and K.J.C. Finnie. 2000. Tachycardia. Canadian Journal of Diagnosis 18 (9): 64-65.

Melendez, L.J., and K.J.C. Finnie. 2000. The Wandering QRS. Canadian Journal of Diagnosis 18 (7): 51-52.
 
 

MOIST, L.

Garg, A.X., P.G. Blake, W.F. Clark, C.M. Clase, R.B. Hanes, and L.M. Moist. 2001. The association between renal insufficiency and malnutrition in community-dwelling older adults. Journal of the American Society of Nephrology 12: A1053.

Garg, A.X., P.G. Blake, W.F. Clark, C.M. Clase, R.B. Haynes, and L.M. Moist. 2001. Association between renal insufficiency and malnutrition in older adults: results from the NHANES III. Kidney International 60 (5): 1867-1874.

Moist, L. 2001. The Renal Effects of Cox-2 Inhibitors. Canadian Journal of Continuing Medical Education (September): 65-76.

Moist, L.M. 2001. Building the evidence in peritoneal dialysis: Use of randomized controlled trials, observational and registry data. Peritoneal Dialysis International 21: S263-S268.

Moist, L.M., F.K. Port, S.M. Orzol, E.W. Young, T. Ostbye, R.A. Wolfe, T. Hulbert-Shearon, C.A. Jones, and W.E. Bloembergen. 2000. Predictors of Loss of Residual Renal Function Among New Dialysis Patients. Journal of American Society of Nephrology 11: 556-564.
 
 

MUIRHEAD, N.

Foly, R.N., P.S. Parfrey, J. Morgan, P.E. Barre, P. Campbell, P. Cartier, D. Coyle, A. Fine, P. Handa, I. Kingma, C.Y. Lau, A. Levin, D. Mendelssohn, N. Muirhead, B. Murphy, R.K. Plante, G. Posen, and G.A. Wells. 2000. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney International 58 (3): 1325-1335.

Lewis, J.F., M.M. Salem, G.M. Chertow, L.S. Weisberg, F. McGrew, T.C. Marbury, and R.L. Allgrenfor The Anaritide Acute Renal Failure Study Group. 2000. Atrial natriuretic factor in oliguric acute renal failure. American Journal of Kidney Diseases 36 (4): 767-774.

Murphy, S.W., R.N. Foley, B.J. Barrett, G.M. Ken, J. Morgan, P. Barre, P. Campbell, A. Fine, M.B. Goldstein, S.P. Handa, K.K. Jindal, A. Levin, H. Mandin, N. Muirhead, R.M. Richardson, and P.S. Parfrey. 2000. Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney International 57 (6): 2557-2563.

Murphy, S.W., R.N. Foley, B.J. Barrett, G.M. Ken, J. Morgan, P. Barre, P. Campbell, A. Fine, M.B. Goldstein, S.P. Handa, K.K. Jindal, A. Levin, H. Mandin, N. Muirhead, R.M. Richardson, and P.S. Parfrey. 2000. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney International 57 (4): 1720-1726.

Tonelli, M., and N. Muirhead. 2000. Access type as a predictor of dialysis adequacy in chronic hemodialysis patients. ASAIO Journal 46 (3): 279-282.
 
 

NIELSON, W.R.

Dijkstra, A., J.W.S. Vlaeyen, H. Rijnen, and W.R. Nielson. 2001. Readiness to adopt the self-management approach to cope with chronic pain in fibromyalgia patients. Pain 90: 37-45.

Jensen, M.P., W.R. Nielson, J.M. Romano, M.L. Hill, and J.A. Turner. 2000. Further evaluation of the Pain Stages of Change Questionnaire: Is the Transtheoretical Model useful for patients with chronic pain? Pain 86: 255-264.

Mior, S., and W.R. Nielson. 2001. Preface: Prevention, treatment and disability management. Clinical Journal of Pain 17: S65-S67.

Nielson, W.R. 2001. The concept of pain. Clinical Journal of Pain 17: S5-S7.

Nielson, W.R., M.P. Jensen, and M.L. Hill. 2001. An activity pacing scale for the Chronic Pain Coping Inventory: Development in a sample of patients with Fibromyalgia Syndrome. Pain 89: 111-115.

Nielson, W.R., and H. Merskey. 2001. Psychosocial aspects of fibromyalgia. Current Pain and Headache Reports 5: 330-337.

Nielson, W.R., and S. Mior. 2001. Prevention of chronic pain: The unexplored frontier. Clinical Journal of Pain 17: S68-S69.

Nielson, W.R., and R. Weir. 2001. Biopsychosocial approaches to the treatment of chronic pain. Clinical Journal of Pain 17: S114-S127.

Weir, R., and W.R. Nielson. 2001. Interventions for disability management. Clinical Journal of Pain 17: S128-S132.

White, K.P., T. Ostbye, M. Harth, W. Nielson, M. Speechley, R. Teasell, and R. Bourne. 2000. Perspectives on post-traumatic fibromyalgia: A random survey of Canadian general practitioners, orthopedists, physiatrists and rheumatologists. Journal of Rheumatology 27: 790-796.
 
 

PATERSON, N.A.M.

Newman, J. 2001. The role of dornase alpha in the treatment of severe cystic fibrosis. Canadian Journal of Hospital Pharmacy 54: 40-42.
 
 

PICKERING, J.G.

Chow, L.H., D.R. Boughner, J. Dunmore-Buyze, H. Finlay, and J.G. Pickering. 2001. Enhanced detection of cardiac muscle damage by polarized light microscopy: Use in a model of coxsackievirus B3-induced myocarditis. Journal of Cardiovascular Pathology 10: 83-86.

Karkanis, T., Y. Jiao, B.R. Hurley, S. Li, J.G. Pickering, and S.M. Sims. 2001. Functional receptor-channel coupling compared in contractile and proliferative human vascular smooth muscle. Journal of Cellular Physiology 187: 244-255.

Li, J., X. Han, J. Jiang, R. Zhong, G.M. Williams, J.G. Pickering, and L.H. Chow. 2001. Vascular smooth muscle cells of recipient origin mediate intimal expansion following aortic allotransplantation in mice. American Journal of Pathology 158: 1943-1947.

Li, S., L.H. Chow, and J.G. Pickering. 2000. Cell surface-bound collagenase-1 and focal substrate degradation stimulate the rear release of motile vascular smooth muscle cells. Journal of Biological Chemistry 275: 35384-35392.

Pickering, J.G. 2001. Regulation of vascular cell behaviour by collagen: Form is function. Circulation Research 88: 458-459.

Rocnik, E., L. Saward, and J.G. Pickering. 2001. Hsp47 is expressed during arterial development and neointimal formation: association with smooth muscle cell differentiation state and regulation by polymerized collagen. Arteriosclerosis, Thrombosis, and Vascular Biology 21: 40-46.
 
 

POPE, J.E.

Hong, P., J. Pope, and J. Ouimet. 2001. Sexual dysfunction in men with rheumatic diseases: is scleroderma positively correlated with impotence? Arthritis and Rheumatism 44 (9): S328.

Pope, J., and A. Thompson. 2000. The Frequency and signigicance of anticardiolipin antibodies in Scleroderma. The Journal of Rheumatology 27: 1450-1452.

Silverstein, F.E., G. Faich, and J.L. Goldstein. 2000. Gastrointestinal toxicity with Celecoxib vs. nonsteroidal anti-inflammatory. JAMA 284 (10): 1247-55.

Veale, D., U. Feron, K. Hensha, H. Johnston, N. Reay, J. Pope, and D. Furst. 2001. The Scleroderma Clinical Trials Consortium United Kingdom: Clinical and laboratory measures of disease activity in systemic sclerosis. Arthritis and Rheumatism 44 (9): S327.
 
 

RODGER, N.W.

Mitek, N., C. Tudor-Locke, N.W. Rodger, R. Bell, A. Myers, and N. Ecclestone. 2001. Effectiveness of Physical Activity Intervention for Individuals with Type 2 Diabetes. Canadian Journal of Diabetes Care 25: 228.

Rodger, N., and W. Furtado. 2001. Assessment of the Usefulness of a Palm-top Computer in Teaching Insulin Adjustments to Patients with Type 1 Diabetes. Canadian Journal of Diabetes Care. 25. 198.

Rodger, N.W. 2001. The Diabetes Council of Canada (DCC): Co-ordinating National Diabetes Strategies. Advances in Experimental Medicine and Biology. 498. Diabetes and Cardiovascular disease: Etiology. A. Angel, N.S. Dhalla, G.N. Pierce, and P.K. Singal. New York: Kluwer Academic/ Plenum Publishers. 401-3.

Rodger, N.W., C.A. Hernandez, and M. Hume. 2001. Six-month evaluation of a self-awareness intervention for individuals with Type 1 Diabetes. Canadian Journal of Diabetes Care 25: 196.

Tudor-Locke, C., A.M. Myers, and N.W. Rodger. 2001. Development of a Theory-based Daily Activity Intervention for Individuals with Type 2 Diabetes. Diabetes Educator 27: 85-94.
 
 

SKANES, A.C.

Chauhan, V.S., A.D. Krahn, G.J. Klein, A.C. Skanes, and R. Yee. 2001. Supraventricular tachycardia. Medical Clinics of North America 85 (2): 193-223.

Klein, G.J., A.D. Krahn, R. Yee, and A.C. Skanes. 2000. The implantable loop recorder: The herald of a new age of implantable monitors. PACE 23: 1456.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Randomized assessment of syncope trial: Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104: 46-51.

Krahn, A.D., P. Nguyen-Ho, G.J. Klein, R. Yee, A.C. Skanes, and N. Suskin. 2001. An electrocardiographic derivative of QT prolongation. 1: 111-116.

Krahn, A.D., S.M. Renner, G.J. Klein, R. Yee, A. Skanes, and E.M. Evans. 2000. The utility of holter monitoring compared to loop recorders in the evaluation of syncope and presyncope. Annals of Noninvasive Electrocardiology 5 (3): 284-289.

Lee, JK., GJ. Klein, AD. Krahn, R. Yee, K. Zarnke, C. Simpson, A. Skanes, and B. Spindler. 2000. Rate control versus conversion strategy in postoperative atrial fibrillation: a prospective randomized pilot study. American Heart Journal 140 (6): 871-877.

LeLorier, P., G.J. Klein, A. Krahn, R. Yee, and A. Skanes. 2001. Should patients with asymptomatic Wolff-Parkinson-White pattern undergo a catheter ablation. Current Cardiology Reports : 301-304.

Simpson, C.S., G.J. Klein, FJ. Brennan, A.D. Krahn, R. Yee, and A.C. Skanes. 2000. Impact of a mandatory physician reporting system for cardiac patients potentially unfit to drive. Canadian Journal of Cardiolovy 16 (10): 1257-1263.

Simpson, C.S., R. Yee, J.K. Lee, M. Braney, G.J. Klein, A.D. Krahn, and A.C. Skanes. 2001. Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. American Heart Journal 142 (2): 294-300.

Skanes, A.C., M. Dubuc, G.J. Klein, B. Thibault, A.D. Krahn, R. Yee, D. Roy, P. Guerra, and M. Talajic. 2000. Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation 102 (13): 2856-2860.

Skanes, A.C., R. Yee, A.D. Krahn, and G.J. Klein. 2001. Should ablative therapy be first-line therapy for idiopathic atrial fibrillation? Journal of Invasive Cardiology 13 (7): 563-568.
 
 

SUE-A-QUAN, G.

Feagan, B.G., C.J. Wong, C.Y. Lau, S.L. Wheeler, G. Sue-A-Quan, and A. Kirkley. 2001. Transfusion practice in elective orthopaedic surgery. Transfusion Medicine 11 (2): 87-95.
 
 

VELDHUIZEN, R.A.W.

Brackenbury, A., P. Puligandla, L. McCaig, V. Nikore, L.J. Yao, R. Veldhuizen, and J.F. Lewis. 2001. Evaluation of exogenous surfactant in HCl-induced lung injury. American Journal of Respiratory and Critical Care Medicine 163 (5): 1135-1142.

Kerr, C., R. Veldhuizen, and J.F. Lewis. 2001. Effects of high frequency oscillation on alveolar surfactant aggregates in an acute lung injury model. American Journal of Respiratory and Critical Care Medicine 164: 237-242.

Malloy, J.L., R.A.W. Veldhuizen, and J.F. Lewis. 2000. Effects of ventilation on the surfactant system in sepsis-induced lung injury. Journal of Applied Physiology 88 (2): 401-408.

Nakamura, T., R. Veldhuizen, L.-J. Yao, L. McCaig, J.F. Lewis, and J. Malloy. 2001. Mechanical ventilation of isolated septic rat lungs: effects on surfactant and inflammatory cytokines. Journal of Applied Physiology 91 (2): 811-820.

Puligandla, P.S., T. Gill, L.A. McCaig, L.-J. Yao, R.A.W. Veldhuizen, F. Possmayer, and J.F. Lewis. 2000. The alveolar environment influences the metabolic and biophysical properties of exogenous surfactants. Journal of Applied Physiology 88 (3): 1061-1071.

Ribeiro, S.P., K. Rhee, L.N. Tremblay, R. Veldhuizen, J.F. Lewis, and A.S. Slutsky. 2001. Heat stress attenuates ventilatory-induced lung dysfunction in an ex vivo rat lung model. American Journal of Respiratory and Critical Care Medicine 163 (6): 1451-1456.

Veldhuizen, R.A.W., L.N. Tremblay, A. Godvindarajan, B.A.W.M. Van Roozendaal, H.P. Haagsman, and A.S. Slutsky. 2000. Pulmonary surfactant is altered during mechanical ventilation of isolated rat lung. Critical Care Medicine 28 (7): 2545-2551.

Yao, L.-J., S. Samuelson, L. Fraher, P. Borron, R.A.W. Veldhuizen, J.L. Malloy, L.A. McCaig, and J.F. Lewis. 2001. Effects of alveolar surfactant aggregates on T-lymphocyte proliferation. Biochimica Et Biophysica Acta 1535 (3): 266-274.
 
 

WATSON, P.H.

Canaff, L., J.-L. Petit, M. Kisiel, P.H. Watson, M. Gascon-Barre, and G.N. Hendy. 2001. Extracellular calcium-sensing receptor is expressed in rat hepatocytes: coupling to intracellular calcium mobilization and stimulation of bile flow. Journal of Biological Chemistry 276: 4070-4079.

Dempster, D.W., H. Zhou, F. Cosman, J. Nieves, L.J. Fraher, P.H. Watson, R. Lindsay, and A.B. Hodsman. 2001. PTH Treatment Directly Stimulates Bone Formation on Cancellous, Endocortical and Periosteal Surfaces in Humans. Journal of Bone and Mineral Research 16: S179.

Hodsman, A.B., D.A. Hanley, P.H. Watson, and L.J. Fraher. 2001. Pharmacologic mechanisms of therapeutics: parathyroid hormone. Principles of Bone Biology. 2. 2 ed. J.P. Bilezekian, and B. Royce. San Diego, CA: Academic Press. 1305-1324.

Patterson, E., L. Canaff, G.N. Hendy, A.B. Hodsman, L.J. Fraher, and P.H. Watson. 2001. Intracellular localization of green fluorescent protein-PTH receptor constructs in cultured LLC-PK1 cells: targeted mutagenesis of the putative nuclear localization sequence. Bone 28: S143.

Patterson, E., P.H. Watson, L.E. Canaff, G.N. Hendy, R. Bringhurst, A.B. Hodsman, and L.J. Fraher. 2001. Transient expression of GFP-PTH/PTHrP receptor constructs in LLC-PK1 (clone 46) cells. Journal of Bone and Mineral Research 16: S549.

Watson PH, W.M.W.A. 2001. Characterization of an ovarian PTHrP pathway that promotes bovine early development in vitro. Anatomy and Emryology 203: 175-184.
 
 

WHITE, K.P.

Huisman, A.M., K.P. White, A. Algra, M. Harth, R. Vieth, J.W.G. Jacobs, J.W.J. Bijlsma, and D.A. Bell. 2000. Vitamin D in female systemic lupus erythematosus and fibromyalgia patients. Arthritis and Rheumatism 43 (9): S1092.

Thomas, A., K.P. White, and F. Prato. 2000. A comparison of rheumatoid arthritis (RA) and fibromyalgia (FM) patients and healthy controls. Arthritis and Rheumatism 43 (9): S881.

Thomas, AW., KP. White, DJ. Drost, and F. Prato. 2000. A comparison of rheumatoid arthritis (RA) and fibromyalgia (FM) patients and healthy controls. Neuroscience Letters 309 (1): 17-20.

White, K.P., S. Carette, M. Harth, and R.W. Teasell. 2000. Trauma and fibromyalgia: Is there an association and what does it mean? Seminars in Arthritis and Rheumatism 29: 200-216.

White, K.P., and M. Harth. 2001. Classification, Epidemiology and Natural History of Fibromyalgia. Current Pain and Headache Reports 5 (4): 320-329.

White, K.P., and M. Harth. 2001. Lumbar pannus presenting as cauda equina syndrome in a patient with longstanding rheumatoid arthritis. The Journal of Rheumatology 28: 627-30.

White, K.P., M. Harth, M. Speechley, and T. Ostbye. 2000. Fibromyalgia (FMS) tender points in FMS cases from the general population: Testing construct validity and reliability. Journal of Rheumatology 27 (11): 2677-82.

White, K.P., W. Nielson, M. Harth, M. Speechley, and T. Ostbye. 2000. Does the label fibromyalgia alter health status and function: a prospective, within-group comparison? Arthritis and Rheumatism 43 (9): S871.

White, K.P., W. Nielson, M. Harth, M. Speechley, and T. Ostbye. 2000. Does the label fibromyalgia alter health status, function and health services utilization? A between-group comparison? Arthritis and Rheumatism 43 (9): S870.

White, K.P., T. Ostbye, M. Harth, W. Nielson, M. Speechley, R. Teasell, and R. Bourne. 2000. Perspectives on post-traumatic fibromyalgia: A random survey of Canadian general practitioners, orthopedists, physiatrists and rheumatologists. Journal of Rheumatology 27: 790-796.

White, K.P., M. Speechley, M. Harth, and T. Ostbye. 2000. Co-existence of chronic fatigue syndrome (CFS) with fibromyalgia syndrome (FMS) in the general population: A controlled study. Scandanavian Journal of Rheumatology 26 (2): 244-6.

White, KP., M. Harth, M. Speechley, and T. Ostbye. 2000. Testing the consistency of the diagnosis of fibromyalgia (FM) over time: a 36 month study in a representative sample of 99 community adults with chronic widespread pain. Arthritis and Rheumatism 43 (9): S869.
 
 

WISENBERG, G.

Lekx, K. 2001. Development of a canine model of hibernating myocardium and its use to validate corresponding MRI. Proceedings of Society of Cardiac Magnetic Resonance Imaging . San Francisco, California: Society of Cardiac Magnetic Resonance. 103.

Pereira, R.S., G. Wisenberg, F.S. Prato, and K. Yvorchuk. 2000. Clinical Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA. MAGMA 11 (3): 104-113.
 
 

YEE, R.

Gillis, A.M., S.J. Connolly, M. Dubuc, R. Yee, P. Lacomb, F. Philippon, C.R. Kerr, S. Kimber, M.J. Gardner, A.S.L. Tans, F. Molin, D. Newman, and H. Abdollah. 2001. Circadian variation of paroxysmal atrial fibrillation. The American Journal of Cardiology 87: 794-798.

Gillis, A.M., S.J. Connolly, P. Lacombe, F. Philippon, M. Dubuc, C.R. Kerr, R. Yee, S. Rose, D. Newman, K.M. Kavanagh, M.J. Gardner, T. Kuss, and G. Wyse. 2000. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. Circulation 102: 736-741.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. The predictive value of presyncope in patients monitored for assessment of syncope. American Heart Journal 141 (5): 817-821.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Randomized assessment of syncope trial: Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104: 46-51.

Krahn, A.D., P. Nyugen-Ho, G.J. Klein, R. Yee, A.C. Skanes, and N. Suskin. 2001. QT dispersion: An electrocardiographic derivative of QT prolongation. American Heart Journal 141 (1): 111-116.

Krahn, A.D., S.M. Renner, G.J. Klein, R. Yee, A. Skanes, and E.M. Evans. 2000. The utility of holter monitoring compared to loop recorders in the evaluation of syncope and presyncope. Annals of Noninvasive Electrocardiology 5 (3): 284-289.

Krahn, A.D., J. Wang, B. Spindler, A.C. Skanes, R. Yee, G.J. Klein, and R.A. Hegele. 2000. A novel mutation in KVLQT1, L122P, found in a family with autosomal doinant long QT syndrome. American Heart Journal 140: 146-149.

Simpson, C.S., M.A. Barlow, A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2000. Recurrent seizure diagnosed by the insertable loop recorder (ILR). Journal of Interventional Cardiac Electrophysiology 4: 475-479.

Simpson, C.S., G.J. Klein, FJ. Brennan, A.D. Krahn, R. Yee, and A.C. Skanes. 2000. Impact of a mandatory physician reporting system for cardiac patients potentially unfit to drive. Canadian Journal of Cardiolovy 16 (10): 1257-1263.

Simpson, C.S., R. Yee, J.K. Lee, M. Braney, G.J. Klein, A.D. Krahn, and A.C. Skanes. 2001. Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. American Heart Journal 142 (2): 294-300.

Skanes, A.C., A.D. Krahn, R. Yee, G.J. Klein, S.J. Connolly, C.R. Kerr, M. Gent, K.E. Thorpe, R.S. Roberts, and for the CTOPP Investigators. 2001. Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing. Journal of the American College of Cardiology 38 (1): 167-172.

Skanes, A.C., R. Yee, A.D. Krahn, and G.J. Klein. 2001. Should ablative therapy be first-line therapy for idiopathic atrial fibrillation? Journal of Invasive Cardiology 13 (7): 563-568.
 
 

ZARNKE, K.B.

McAlister, F.A., N. Campbell, K.B. Zarnke, M. Levine, and I.D. Graham. 2001. Guidelines and the management of hypertensive patients in Canada:Impact, shortcomings and implications for the future. Canadian Medical Association Journal 164 (4): 519-22.

McAlister, F.A., M. Levine, K.B. Zarnke, N. Campbell, R. Lewanczuk, F. Leenen, S. Rabkin, J.M. Wright, J. Stone, R.D. Feldman, M. Lebel, G. Honos, G. Fodor, E. Burgess, S. Tobe, P. Hamet, R. Herman, J. Irvine, B. Culleton, R. Petrella, and R. Touyz for the Canadian Hypertension Recommendations Working Group. 2001. The 2000 Canadian recommendations for the management of hypertension: Part 1 Therapy. Canadian Journal of Cardiology 17 (5): 543-559.

Pressel, S., B.R. Davis, G.T. Louis, P. Whelton, H. Adrogue, D. Egan, M. Farber, G. Patyne, J. Probstfield, and H. Ward for the ALLHAT Research Group (including K.B. Zarnke). 2001. Participant recruitment in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Controlled Clinical Trials 22 (6): 674-686.